DAKTARIN Side Effects

7020756-1 | Hyperaemia, Pigmentation Disorder, Priapism
on Sep 21, 2010 Male patient from CHINA , 69 years of age, was diagnosed with pruritus and was treated with Daktarin (View Usage). Patient experienced the following unwanted or unexpected effects: hyperaemia, pigmentation disorder, priapism. Daktarin dosage: .

6900599-7 | Blood Urine Present
Patient was taking Daktarin (View Usage). Patient had the following side effects: blood urine present on Jul 21, 2010 from FRANCE Additional patient health information: Male patient , 66 years of age, was diagnosed with mouth ulceration and. Daktarin dosage: . During the same period patient was treated with SINTROM (View Sintrom Review and Sintrom Label ).

6816838-7 | Hypersensitivity, Paraesthesia Oral, Respiratory Arrest
Adverse event was reported on Jun 30, 2010 by a Female patient taking Daktarin (View Usage) (Dosage: ) was diagnosed with oral candidiasis and. Location: UNITED KINGDOM , weighting 11.82 lb, After Daktarin was administered, patient had the following side effects: hypersensitivity, paraesthesia oral, respiratory arrest. During the same period patient was treated with NYSTATIN (View Nystatin Review and Nystatin Label ).

6723214-4 | Dyspnoea
on May 07, 2010 Female patient from BRAZIL , weighting 7.94 lb, was diagnosed with bacterial infection (What is bacterial infection?) and was treated with Daktarin (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea. Daktarin dosage: .


6681049-5 | International Normalised Ratio Increased
on Apr 13, 2010 Female patient from NETHERLANDS , 69 years of age, was diagnosed with mycosis fungoides and was treated with Daktarin (View Usage). Patient had the following side effects: international normalised ratio increased. Daktarin dosage: . During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), CHLORTHALIDONE (View Chlorthalidone Review and Chlorthalidone Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6681048-3 | Epistaxis, International Normalised Ratio Increased
Patient was taking Daktarin (View Usage). After Daktarin was administered, patient had the following side effects: epistaxis, international normalised ratio increased on Apr 13, 2010 from NETHERLANDS Additional patient health information: Female patient , 88 years of age, was diagnosed with erythema, vascular occlusion and. Daktarin dosage: . During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), NITRENDIPINE (View Nitrendipine Review and Nitrendipine Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), TOLBUTAMIDE (View Tolbutamide Review and Tolbutamide Label ), IRBESARTAN AND HYDROCHLOROTHIAZIDE (View Irbesartan And Hydrochlorothiazide Review and Irbesartan And Hydrochlorothiazide Label ).

6681044-6 | International Normalised Ratio Increased
Adverse event was reported on Apr 13, 2010 by a Male patient taking Daktarin (View Usage) (Dosage: ) was diagnosed with fungal skin infection and. Location: NETHERLANDS , 59 years of age, Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ).

6681043-4 | International Normalised Ratio Increased
on Apr 13, 2010 Male patient from NETHERLANDS , 73 years of age, was diagnosed with respiratory tract infection and was treated with Daktarin (View Usage). Patient had the following side effects: international normalised ratio increased. Daktarin dosage: . During the same period patient was treated with DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), INSULIN (View Insulin Review and Insulin Label ), FLAMMAZINE (View Flammazine Review and Flammazine Label ), CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), LACTULOSE (View Lactulose Review and Lactulose Label ).

6681042-2 | International Normalised Ratio Increased
on Apr 13, 2010 Female patient from NETHERLANDS , 77 years of age, was diagnosed with fungal skin infection and was treated with Daktarin (View Usage). After Daktarin was administered, patient had the following side effects: international normalised ratio increased. Daktarin dosage: . During the same period patient was treated with PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ).

6680988-9 | International Normalised Ratio Increased
Patient was taking Daktarin (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased on Apr 13, 2010 from NETHERLANDS Additional patient health information: Female patient , 77 years of age, was diagnosed with rash (What is rash?) and. Daktarin dosage: . During the same period patient was treated with PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ).

6581329-8 | Haematuria, International Normalised Ratio Increased, Overdose
Adverse event was reported on Jan 04, 2010 by a Female patient taking Daktarin (View Usage) (Dosage: ) was diagnosed with tongue coated and. Location: FRANCE , 67 years of age, Patient had the following side effects: haematuria, international normalised ratio increased, overdose. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), SECTRAL (View Sectral Review and Sectral Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ). Patient was hospitalized.

6575506-X | Hypoglycaemia, Motor Dysfunction
on Nov 05, 2009 Male patient from FRANCE , 67 years of age, was diagnosed with oral fungal infection, type 2 diabetes mellitus and was treated with Daktarin (View Usage). After Daktarin was administered, patient had the following side effects: hypoglycaemia, motor dysfunction. Daktarin dosage: . During the same period patient was treated with DAONIL (View Daonil Review and Daonil Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), COZAAR (View Cozaar Review and Cozaar Label ), ENDOTELON (View Endotelon Review and Endotelon Label ), TANAKAN (View Tanakan Review and Tanakan Label ). Patient was hospitalized.

6535364-6 | Haematuria, International Normalised Ratio Increased, Overdose
on Jan 04, 2010 Female patient from FRANCE , 67 years of age, was diagnosed with tongue coated and was treated with Daktarin (View Usage). Patient experienced the following unwanted or unexpected effects: haematuria, international normalised ratio increased, overdose. Daktarin dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), SECTRAL (View Sectral Review and Sectral Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ). Patient was hospitalized.

6450069-8 | Hypoglycaemia, Motor Dysfunction
Patient was taking Daktarin (View Usage). Patient had the following side effects: hypoglycaemia, motor dysfunction on Nov 20, 2009 from FRANCE Additional patient health information: Male patient , 67 years of age, was diagnosed with oral fungal infection, type 2 diabetes mellitus and. Daktarin dosage: . During the same period patient was treated with DAONIL (View Daonil Review and Daonil Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), COZAAR (View Cozaar Review and Cozaar Label ), ENDOTELON (View Endotelon Review and Endotelon Label ), TANAKAN (View Tanakan Review and Tanakan Label ). Patient was hospitalized.

6438810-1 | Hypoglycaemia, Motor Dysfunction
Adverse event was reported on Nov 05, 2009 by a Male patient taking Daktarin (View Usage) (Dosage: ) was diagnosed with oral fungal infection, type 2 diabetes mellitus and. Location: FRANCE , 67 years of age, After Daktarin was administered, patient had the following side effects: hypoglycaemia, motor dysfunction. During the same period patient was treated with DAONIL (View Daonil Review and Daonil Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), COZAAR (View Cozaar Review and Cozaar Label ), ENDOTELON (View Endotelon Review and Endotelon Label ), TANAKAN (View Tanakan Review and Tanakan Label ). Patient was hospitalized.

6435037-4 | Hypoglycaemia, Motor Dysfunction
on Nov 05, 2009 Male patient from FRANCE , 67 years of age, was diagnosed with oral fungal infection, type 2 diabetes mellitus and was treated with Daktarin (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, motor dysfunction. Daktarin dosage: . During the same period patient was treated with DAONIL (View Daonil Review and Daonil Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), COZAAR (View Cozaar Review and Cozaar Label ), ENDOTELON (View Endotelon Review and Endotelon Label ), TANAKAN (View Tanakan Review and Tanakan Label ). Patient was hospitalized.

6435036-2 | Erectile Dysfunction
on Nov 02, 2009 Male patient from CHINA , 30 years of age, was diagnosed with pruritus and was treated with Daktarin (View Usage). Patient had the following side effects: erectile dysfunction (What is erectile dysfunction?). Daktarin dosage: .

6330868-3 | Epistaxis, International Normalised Ratio Increased
Patient was taking Daktarin (View Usage). After Daktarin was administered, patient had the following side effects: epistaxis, international normalised ratio increased on Aug 07, 2009 from NETHERLANDS Additional patient health information: Female patient , 88 years of age, was diagnosed with erythema, vascular occlusion and. Daktarin dosage: . During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), NITRENDIPINE (View Nitrendipine Review and Nitrendipine Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), TOLBUTAMIDE (View Tolbutamide Review and Tolbutamide Label ), IRBESARTAN HYDROCHLOROTHIAZIDE (View Irbesartan - Hydrochlorothiazide Review and Irbesartan - Hydrochlorothiazide Label ).

6330867-1 | International Normalised Ratio Increased
Adverse event was reported on Aug 07, 2009 by a Male patient taking Daktarin (View Usage) (Dosage: ) was diagnosed with fungal skin infection and. Location: NETHERLANDS , 59 years of age, Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), SOTALOL HYDROCHLORIDE (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ), LOSARTAN (View Losartan Review and Losartan Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ).

6327327-0 | Abortion Spontaneous
on Aug 12, 2009 Female patient from CHINA , 37 years of age, was diagnosed with tinea pedis and was treated with Daktarin (View Usage). Patient had the following side effects: abortion spontaneous. Daktarin dosage: .

6327180-5 | International Normalised Ratio Increased
on Aug 07, 2009 Female patient from NETHERLANDS , 69 years of age, was diagnosed with mycosis fungoides and was treated with Daktarin (View Usage). After Daktarin was administered, patient had the following side effects: international normalised ratio increased. Daktarin dosage: . During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), CHLORTHALIDONE (View Chlorthalidone Review and Chlorthalidone Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6327179-9 | International Normalised Ratio Increased
Patient was taking Daktarin (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased on Aug 07, 2009 from GERMANY Additional patient health information: Female patient , 69 years of age, was diagnosed with mycosis fungoides and. Daktarin dosage: . During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), CHLORTHALIDONE (View Chlorthalidone Review and Chlorthalidone Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6327175-1 | Epistaxis, International Normalised Ratio Increased
Adverse event was reported on Aug 07, 2009 by a Female patient taking Daktarin (View Usage) (Dosage: ) was diagnosed with erythema, vascular occlusion and. Location: NETHERLANDS , 88 years of age, Patient had the following side effects: epistaxis, international normalised ratio increased. During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), NITRENDIPINE (View Nitrendipine Review and Nitrendipine Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), TOLBUTAMIDE (View Tolbutamide Review and Tolbutamide Label ), IRBESARTAN HYDROCHLOROTHIAZIDE (View Irbesartan - Hydrochlorothiazide Review and Irbesartan - Hydrochlorothiazide Label ).

6327174-X | International Normalised Ratio Increased
on Aug 07, 2009 Male patient from NETHERLANDS , 59 years of age, was diagnosed with fungal skin infection and was treated with Daktarin (View Usage). After Daktarin was administered, patient had the following side effects: international normalised ratio increased. Daktarin dosage: . During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), SOTALOL HYDROCHLORIDE (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ), LOSARTAN (View Losartan Review and Losartan Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ).

6326084-1 | International Normalised Ratio Increased
on Aug 07, 2009 Female patient from GERMANY , 69 years of age, was diagnosed with mycosis fungoides and was treated with Daktarin (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. Daktarin dosage: . During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), CHLORTHALIDONE (View Chlorthalidone Review and Chlorthalidone Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6325019-5 | International Normalised Ratio Increased
Patient was taking Daktarin (View Usage). Patient had the following side effects: international normalised ratio increased on Aug 07, 2009 from NETHERLANDS Additional patient health information: Female patient , 77 years of age, was diagnosed with fungal skin infection and. Daktarin dosage: . During the same period patient was treated with PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LOSARTAN (View Losartan Review and Losartan Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ).

6325018-3 | International Normalised Ratio Increased
Adverse event was reported on Aug 07, 2009 by a Male patient taking Daktarin (View Usage) (Dosage: ) was diagnosed with respiratory tract infection and. Location: NETHERLANDS , 73 years of age, After Daktarin was administered, patient had the following side effects: international normalised ratio increased. During the same period patient was treated with DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), INSULIN (View Insulin Review and Insulin Label ), FLAMMAZINE (View Flammazine Review and Flammazine Label ), CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), LACTULOSE (View Lactulose Review and Lactulose Label ).

6322129-3 | International Normalised Ratio Increased
on Aug 07, 2009 Female patient from NETHERLANDS , 77 years of age, was diagnosed with rash (What is rash?) and was treated with Daktarin (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. Daktarin dosage: . During the same period patient was treated with PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LOSARTAN (View Losartan Review and Losartan Label ).

6273186-4 | Blister, Pruritus, Rash Erythematous
on Jul 13, 2009 Male patient from CHINA , 62 years of age, was diagnosed with tinea pedis and was treated with Daktarin (View Usage). Patient had the following side effects: blister, pruritus, rash erythematous. Daktarin dosage: .

6203110-1 | Asphyxia, Vomiting
Patient was taking Daktarin (View Usage). After Daktarin was administered, patient had the following side effects: asphyxia, vomiting on May 18, 2009 from BRAZIL Additional patient health information: Male patient , weighting 8.38 lb, was diagnosed with oral candidiasis and. Daktarin dosage: .

6094881-6 | Arthralgia, Dyspepsia, Eructation, Throat Irritation, Tongue Discolouration
Adverse event was reported on Feb 18, 2009 by a Male patient taking Daktarin (View Usage) (Dosage: ) was diagnosed with gingivitis, cardiac disorder, hypercholesterolaemia and. Location: FRANCE , weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: arthralgia, dyspepsia, eructation, throat irritation, tongue discolouration. During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ), AMLOR (View Amlor Review and Amlor Label ), CRESTOR (View Crestor Review and Crestor Label ).

5600877-8 | Dermatomyositis
on Jan 16, 2008 Male patient from NETHERLANDS , weighting 154.3 lb, was diagnosed with oral candidiasis and was treated with Daktarin (View Usage). Patient had the following side effects: dermatomyositis. Daktarin dosage: . During the same period patient was treated with TRISPORAL (View Trisporal Review and Trisporal Label ), FLAGYL (View Flagyl Review and Flagyl Label ). Patient was hospitalized.

5598453-9 | Haematoma
on Jan 14, 2008 Female patient from FRANCE , 92 years of age, was diagnosed with fungal infection (What is fungal infection?) and was treated with Daktarin (View Usage). After Daktarin was administered, patient had the following side effects: haematoma. Daktarin dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), TRIATEC (View Triatec Review and Triatec Label ), CORDARONE (View Cordarone Review and Cordarone Label ), TIAPRIDAL (View Tiapridal Review and Tiapridal Label ), TRANXENE (View Tranxene Review and Tranxene Label ), ARICEPT (View Aricept Review and Aricept Label ), NEULEPTIL (View Neuleptil Review and Neuleptil Label ). Patient was hospitalized.

5597413-1 | Blood Urine Present, Computerised Tomogram Abnormal, Haemorrhage, International Normalised Ratio Increased
Patient was taking Daktarin (View Usage). Patient experienced the following unwanted or unexpected effects: blood urine present, computerised tomogram abnormal, haemorrhage, international normalised ratio increased on Jan 08, 2008 from UNITED KINGDOM Additional patient health information: Female patient , weighting 162.5 lb, was diagnosed with oral candidiasis, thrombosis, polycythaemia, diabetes mellitus and. Daktarin dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), METFORMIN (View Metformin Review and Metformin Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ). Patient was hospitalized.

5525464-1 | Somnolence
Adverse event was reported on Nov 15, 2007 by a Female patient taking Daktarin (View Usage) (Dosage: Dose Applied To Mother's Nipples) was diagnosed with oral candidiasis and. Location: NETHERLANDS , weighting 7.94 lb, Patient had the following side effects: somnolence.

5490796-2 | Accidental Exposure, Vomiting
on Oct 11, 2007 Female patient from BRAZIL , child 3 years of age, was diagnosed with accidental exposure and was treated with Daktarin (View Usage). After Daktarin was administered, patient had the following side effects: accidental exposure, vomiting. Daktarin dosage: .

5368577-X | Dysphagia
on Jun 12, 2007 Male patient from FRANCE , weighting 9.70 lb, was diagnosed with candidiasis and was treated with Daktarin (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia. Daktarin dosage: . Patient was hospitalized.

5353511-9 | Dysphonia, Dyspnoea
Patient was taking Daktarin (View Usage). Patient had the following side effects: dysphonia, dyspnoea on Jun 01, 2007 from BRAZIL Additional patient health information: Male patient , weighting 17.64 lb, was diagnosed with oral candidiasis and. Daktarin dosage: . During the same period patient was treated with NYSTATIN (View Nystatin Review and Nystatin Label ).

5311028-1 | Haematuria, International Normalised Ratio Increased, Rectal Haemorrhage
Adverse event was reported on Apr 18, 2007 by a Female patient taking Daktarin (View Usage) (Dosage: ) was diagnosed with oral candidiasis, atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED KINGDOM , 83 years of age, weighting 132.3 lb, After Daktarin was administered, patient had the following side effects: haematuria, international normalised ratio increased, rectal haemorrhage. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5297255-0 |
on Apr 05, 2007 Female patient from CHINA , 30 years of age, was diagnosed with tinea pedis and was treated with Daktarin (View Usage). . Daktarin dosage: .

5281918-7 | Haematochezia, Mouth Haemorrhage
on Mar 22, 2007 Male patient from FRANCE , 73 years of age, was treated with Daktarin (View Usage). Patient had the following side effects: haematochezia, mouth haemorrhage. Daktarin dosage: . During the same period patient was treated with FRAXIPARINE (View Fraxiparine Review and Fraxiparine Label ), PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

5266182-7 | Conjunctivitis, Eosinophilia, Face Oedema, Pruritus
Patient was taking Daktarin (View Usage). After Daktarin was administered, patient had the following side effects: conjunctivitis, eosinophilia, face oedema, pruritus on Mar 05, 2007 from FRANCE Additional patient health information: Male patient , 18 years of age, . Daktarin dosage: . During the same period patient was treated with INTETRIX (View Intetrix Review and Intetrix Label ). Patient was hospitalized.

5266021-4 | Dyspnoea, Oedema Mouth
Adverse event was reported on Mar 05, 2007 by a Male patient taking Daktarin (View Usage) (Dosage: ) . Location: FRANCE , 56 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, oedema mouth. During the same period patient was treated with ALODONT (View Alodont Review and Alodont Label ).

5265903-7 | Dyspnoea, Oedema Mouth
on Mar 05, 2007 Male patient from FRANCE , 56 years of age, was treated with Daktarin (View Usage). Patient had the following side effects: dyspnoea, oedema mouth. Daktarin dosage: . During the same period patient was treated with ALODONT (View Alodont Review and Alodont Label ).

5265902-5 | Dyspnoea, Lip Swelling, Swollen Tongue
on Mar 05, 2007 Male patient from FRANCE , 50 years of age, was treated with Daktarin (View Usage). After Daktarin was administered, patient had the following side effects: dyspnoea, lip swelling, swollen tongue. Daktarin dosage: . During the same period patient was treated with DOLIPRANE (View Doliprane Review and Doliprane Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5203350-4 | Dyspnoea
Patient was taking Daktarin (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea on Jan 02, 2007 from BRAZIL Additional patient health information: Female patient , weighting 8.82 lb, was diagnosed with oral candidiasis and. Daktarin dosage: 20mg/g, 3 Applications/day, Topical.

5170256-9 | Atrioventricular Block, Bradycardia, Electrocardiogram Qt Prolonged, Electroencephalogram Abnormal, Hyperkalaemia, Hypocalcaemia, Intraventricular Haemorrhage, Ventricular Extrasystoles
Adverse event was reported on Nov 30, 2006 by a Female patient taking Daktarin (View Usage) (Dosage: ) was diagnosed with candidiasis and. Location: FRANCE , weighting 2.65 lb, Patient had the following side effects: atrioventricular block, bradycardia, electrocardiogram qt prolonged, electroencephalogram abnormal, hyperkalaemia, hypocalcaemia, intraventricular haemorrhage, ventricular extrasystoles.

5168341-0 | Epistaxis, Haematoma
on Nov 28, 2006 Female patient from FRANCE , 90 years of age, was diagnosed with oral fungal infection, atrial flutter, hypertensive heart disease, hypercholesterolaemia and was treated with Daktarin (View Usage). After Daktarin was administered, patient had the following side effects: epistaxis, haematoma. Daktarin dosage: . During the same period patient was treated with SINTROM (View Sintrom Review and Sintrom Label ), NEXIUM (View Nexium Review and Nexium Label ), APROVEL (View Aprovel Review and Aprovel Label ), LASIX (View Lasix Review and Lasix Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ADANCOR (View Adancor Review and Adancor Label ). Patient was hospitalized.

5164431-7 | Haematuria
on Nov 27, 2006 Male patient from FRANCE , 64 years of age, was diagnosed with oral candidiasis, portal vein thrombosis, hypertension, respiratory tract infection, chronic obstructive pulmonary disease and was treated with Daktarin (View Usage). Patient experienced the following unwanted or unexpected effects: haematuria. Daktarin dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), BRICANYL (View Bricanyl Review and Bricanyl Label ), KENZEN (View Kenzen Review and Kenzen Label ), MOXIFLOXACIN HYDROCHLORIDE (View Moxifloxacin Hydrochloride Review and Moxifloxacin Hydrochloride Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.

5152886-3 | International Normalised Ratio Increased, Melaena
Patient was taking Daktarin (View Usage). Patient had the following side effects: international normalised ratio increased, melaena on Nov 07, 2006 from UNITED KINGDOM Additional patient health information: Male patient , 68 years of age, . Daktarin dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.